Michael Gaster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michael Gaster has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Henning Beck-Nielsen
KMEB, Department of Endocrinology, Odense University Hospital, DK-5000 Odense , Denmark
5 shared publicationsArild C. Rustan
Department of Pharmacology, School of Pharmacy, University of Oslo, Oslo, Norway
2 shared publicationsH. Beck-Nielsen
Dept. of Endocrinology, Odense University Hospital, 5000 Odense, Denmark
1 shared publicationH. Schrøder
Dept. of Pathology, Odense University Hospital, 5000 Odense, Denmark
1 shared publicationJ. Franch
Institute of Sports Science and Clinical Biomechanics, University of Southern Denmark, Main Campus Odense University, 5000 Odense, Denmark
1 shared publicationJens Knudsen
Institute of Biochemistry, University of Southern Denmark, Odense, Denmark
1 shared publication
Latest Publications
- 1 January 2010
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 391 (3) , 1369-1373
Substrate overload: Glucose oxidation in human myotubes conquers palmitate oxidation through anaplerosis
- 1 January 2010
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 391 (3) , 1369-1373
Substrate overload: Glucose oxidation in human myotubes conquers palmitate oxidation through anaplerosis
- 1 October 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 387 (4) , 651-655
Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?
- 1 October 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 387 (4) , 651-655
Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?
- 1 May 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 382 (4) , 766-770
Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects
- 1 May 2009
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 382 (4) , 766-770
Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects
- 1 January 2009
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1791 (1) , 17-24
The dynamic of lipid oxidation in human myotubes
- 1 January 2009
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1791 (1) , 17-24
The dynamic of lipid oxidation in human myotubes
- 1 July 2007
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1772 (7) , 755-765
Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes
- 1 July 2007
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1772 (7) , 755-765
Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes
- Open Access
- 1 January 2007
- Published by Elsevier in Journal of Lipid Research
- Vol. 48 (1) , 207-217
Metabolic flexibility is conserved in diabetic myotubes
- 1 January 2007
- Published by Elsevier in Journal of Lipid Research
- Vol. 48 (1) , 207-217
Open AccessMetabolic flexibility is conserved in diabetic myotubes
- 31 July 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (7) , 666-672
Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects
- 31 July 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (7) , 666-672
Long-chain Acyl-CoA is not primarily increased in myotubes established from type 2 diabetic subjects
- 1 January 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1761 (1) , 100-110
Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects
- 1 January 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1761 (1) , 100-110
Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects
- 1 March 2005
- Published by American Diabetes Association in Diabetes
- Vol. 54 (3) , 648-656
Differential Utilization of Saturated Palmitate and Unsaturated Oleate
We recently described a primarily reduced palmitate oxidation in myotubes established from type 2 diabetic subjects, whereas triacylglycerol (TAG) accumulation seemed to be adaptive. However, it is still uncertain whether these changes are similar for saturated and unsaturated fatty acids and whether high concentrations of glucose and/or insulin may change this picture. Studies of palmitic acid and oleic acid metabolism in human myotubes established from control and type 2 diabetic subjects under conditions of acute high concentrations of insulin and/or glucose may solve these questions. Total oleic acid and palmitic acid uptake in myotubes was increased during acute insulin stimulation (P < 0.01) but not under acute, high-glucose concentrations, and no differences were found between the groups. Type 2 diabetic myotubes expressed a reduced palmitic acid oxidation to carbon dioxide (P ≤ 0.04), whereas oleic acid oxidation showed no differences between myotubes from both groups. High glucose concentrations decreased oleic acid oxidation (P ≤ 0.03). Lipid distribution was not different in diabetic and control myotubes when palmitic acid and oleic acid incorporation into cellular lipids was compared. Myotubes that were exposed to palmitic acid showed an increased palmitic acid incorporation into diacylglycerol (DAG) and TAG compared with myotubes that were exposed to oleic acid (P < 0.05) expressing an increased intracellular free fatty acid (FFA) level (P < 0.05). Lipid distribution was not affected by high glucose, whereas insulin increased FFAs, DAG, and TAG (P < 0.05). De novo lipid synthesis from glucose in both diabetic and control myotubes was of the same magnitude independent of glucose and insulin concentrations. These results indicate that palmitic acid and oleic acid are utilized in the same pattern in diabetic and control myotubes even though palmitic acid oxidation is primarily reduced in diabetic cells. Palmitic acid and oleic acid are handled differently by myotubes: Palmitic acid seems to accumulate as DAG and TAG, whereas oleic acid accumulates as intracellular FFAs. These observations indicate that oleic acid is preferable as fatty acid as it accumulates to a lesser extent as DAG and TAG than palmitic acid. Neither acute hyperglycemia nor de novo lipid synthesis from glucose seems central to the TAG accumulation in obesity or type 2 diabetes.
- 1 March 2005
- Published by American Diabetes Association in Diabetes
- Vol. 54 (3) , 648-656
Differential Utilization of Saturated Palmitate and Unsaturated Oleate
We recently described a primarily reduced palmitate oxidation in myotubes established from type 2 diabetic subjects, whereas triacylglycerol (TAG) accumulation seemed to be adaptive. However, it is still uncertain whether these changes are similar for saturated and unsaturated fatty acids and whether high concentrations of glucose and/or insulin may change this picture. Studies of palmitic acid and oleic acid metabolism in human myotubes established from control and type 2 diabetic subjects under conditions of acute high concentrations of insulin and/or glucose may solve these questions. Total oleic acid and palmitic acid uptake in myotubes was increased during acute insulin stimulation (P < 0.01) but not under acute, high-glucose concentrations, and no differences were found between the groups. Type 2 diabetic myotubes expressed a reduced palmitic acid oxidation to carbon dioxide (P ≤ 0.04), whereas oleic acid oxidation showed no differences between myotubes from both groups. High glucose concentrations decreased oleic acid oxidation (P ≤ 0.03). Lipid distribution was not different in diabetic and control myotubes when palmitic acid and oleic acid incorporation into cellular lipids was compared. Myotubes that were exposed to palmitic acid showed an increased palmitic acid incorporation into diacylglycerol (DAG) and TAG compared with myotubes that were exposed to oleic acid (P < 0.05) expressing an increased intracellular free fatty acid (FFA) level (P < 0.05). Lipid distribution was not affected by high glucose, whereas insulin increased FFAs, DAG, and TAG (P < 0.05). De novo lipid synthesis from glucose in both diabetic and control myotubes was of the same magnitude independent of glucose and insulin concentrations. These results indicate that palmitic acid and oleic acid are utilized in the same pattern in diabetic and control myotubes even though palmitic acid oxidation is primarily reduced in diabetic cells. Palmitic acid and oleic acid are handled differently by myotubes: Palmitic acid seems to accumulate as DAG and TAG, whereas oleic acid accumulates as intracellular FFAs. These observations indicate that oleic acid is preferable as fatty acid as it accumulates to a lesser extent as DAG and TAG than palmitic acid. Neither acute hyperglycemia nor de novo lipid synthesis from glucose seems central to the TAG accumulation in obesity or type 2 diabetes.